日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma

ALPL-1是骨肉瘤嵌合抗原受体疗法的靶点

Nadia Mensali ,Hakan Köksal # ,Sandy Joaquina # ,Patrik Wernhoff ,Nicholas P Casey ,Paola Romecin ,Carla Panisello ,René Rodriguez ,Lene Vimeux ,Asta Juzeniene ,Marit R Myhre ,Anne Fåne ,Carolina Castilla Ramírez ,Solrun Melkorka Maggadottir ,Adil Doganay Duru ,Anna-Maria Georgoudaki ,Iwona Grad ,Andrés Daniel Maturana ,Gustav Gaudernack ,Gunnar Kvalheim ,Angel M Carcaboso ,Enrique de Alava ,Emmanuel Donnadieu ,Øyvind S Bruland ,Pablo Menendez ,Else Marit Inderberg ,Sébastien Wälchli

miR-486-5p expression is regulated by DNA methylation in osteosarcoma

miR-486-5p 表达受骨肉瘤中 DNA 甲基化的调控

Heidi M Namløs, Magne Skårn, Deeqa Ahmed, Iwona Grad, Kim Andresen, Stine H Kresse, Else Munthe, Massimo Serra, Katia Scotlandi, Antonio Llombart-Bosch, Ola Myklebost, Guro E Lind, Leonardo A Meza-Zepeda

Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening

通过中等规模高通量药物筛选发现抗脂肪肉瘤治疗的新型候选药物

Iwona Grad, Robert Hanes, Pilar Ayuda-Durán, Marieke Lydia Kuijjer, Jorrit M Enserink, Leonardo A Meza-Zepeda, Ola Myklebost

Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma

泛 FGFR 抑制剂 LY2874455 对 FRS2 扩增脂肪肉瘤的临床前评估

Robert Hanes, Else Munthe, Iwona Grad, Jianhua Han, Ida Karlsen, Emmet McCormack, Leonardo A Meza-Zepeda, Eva Wessel Stratford, Ola Myklebost

Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma

去分化脂肪肉瘤潜在治疗靶点的临床前评估

Robert Hanes, Iwona Grad, Susanne Lorenz, Eva W Stratford, Else Munthe, Chilamakuri Chandra Sekhar Reddy, Leonardo A Meza-Zepeda, Ola Myklebost

Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA

let-7a microRNA对转移性乳腺癌和黑色素瘤进行代谢重编程

Anastassia Serguienko, Iwona Grad, Anna B Wennerstrøm, Leonardo A Meza-Zepeda, Bernd Thiede, Eva W Stratford, Ola Myklebost, Else Munthe

Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21

使用来自 21 三体不一致的同卵双胞胎的诱导性多能干细胞来建模和挽救唐氏综合症的神经发育缺陷

Youssef Hibaoui, Iwona Grad, Audrey Letourneau, M Reza Sailani, Sophie Dahoun, Federico A Santoni, Stefania Gimelli, Michel Guipponi, Marie Francoise Pelte, Frédérique Béna, Stylianos E Antonarakis, Anis Feki

The molecular chaperone Hsp90α is required for meiotic progression of spermatocytes beyond pachytene in the mouse

分子伴侣 Hsp90α 是小鼠精母细胞减数分裂进程中粗线期以后所必需的

Iwona Grad, Christopher R Cederroth, Joël Walicki, Corinne Grey, Sofia Barluenga, Nicolas Winssinger, Bernard De Massy, Serge Nef, Didier Picard

p23/Sba1p protects against Hsp90 inhibitors independently of its intrinsic chaperone activity

p23/Sba1p 独立于其内在的伴侣活性,保护细胞免受 Hsp90 抑制剂的侵害

Fedor Forafonov, Oyetunji A Toogun, Iwona Grad, Elena Suslova, Brian C Freeman, Didier Picard